Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

Deal Capsule: Transactions In Chemicals & Pharmaceuticals April 2016

by KPMG
While the number of completed pharma deals were slightly higher in Q1 2016 versus Q1 2015, deal value was far lower in the absence of any >$10 billion completions. Only one deal exceeded $5 billion in Q1 2016 (versus 8 in Q1 2015). Specialization continues to be a driving force in Q1 2016, especially in sectors such as OTC, rare diseases and oncology. Declines in transaction values were also witnessed in chemicals. Downstream specialty chemicals was the leading focus area, notably in applications, resins and agrochemicals. […] Read more

Banking And Capital Markets: Top Trends For M&A In 2016

Banking And Capital Markets: Top Trends For M&A In 2016

by KPMG
2015 was an interesting year by all accounts in the banking sector globally and in particular for M&A activity in the sector. Deal value was up significantly over 2014 and while the level of activity was foreseen by many, the specific nature of what took place varied over many expectations. The level of anticipated activity in parts of Asia was mixed with outward investment continuing to be robust but not perhaps at the level that some had anticipated as market signals in China in particular were largely negative after the midpoint of the year. […] Read more

Global Oil And Gas Transactions Review 2015

Global Oil And Gas Transactions Review 2015

by Ernst & Young
The dramatic drop in both crude oil and natural gas prices across the year combined with a high level of uncertainty about their future trajectory challenged oil and gas merger and acquisition (M&A) activity in 2015. Crude oil prices, which began the year at US$55 per barrel (Brent), declined to US$37 per barrel by December, the lowest level since May 2004 with natural gas prices experiencing a similar journey. […] Read more

2016 Global Chemical Industry Mergers And Acquisitions Outlook: A Quest For Focus

2016 Global Chemical Industry Mergers And Acquisitions Outlook: A Quest For Focus

by Deloitte
In the Deloitte Touche Tohmatsu Limited (Deloitte Global) 2015 Global chemical industry mergers and acquisitions outlook, record levels of chemical mergers and acquisitions (M&A) activity in 2014 were observed, with a prediction that strong M&A momentum would continue in the industry into 2015. While the number of global chemical deals was relatively flat in 2015, the strong M&A momentum has continued with the number of global chemical deals in 2015 exceeding the previous six-year average by over 6 percent. […] Read more

Deals: Is Your Bank Playing Checkers While Other Banks Are Playing Chess?

Deals: Is Your Bank Playing Checkers While Other Banks Are Playing Chess?

by Ernst & Young
Over the past couple of years, regulatory guidelines, requirements and processes that stemmed from the Dodd–Frank Wall Street Reform and Consumer Protection Act (Dodd-Frank) adversely impacted the banking mergers and acquisitions (M&A) market, and transaction activity fell. As the understanding of regulatory guidelines has improved and banking institutions have matured their ability to respond, a new deal environment has begun to emerge, albeit with a tempered degree of enthusiasm. […] Read more

Consumer Currents – Food For Thought: Do Grocers Need To Reinvent Their Business Model?

Consumer Currents - Food For Thought: Do Grocers Need To Reinvent Their Business Model?

by KPMG
As Albert Einstein shrewdly remarked: “If you always do what you always did, you will always get what you always got.” In the consumer marketplace in the 21st century we live in an age where innovation and reinvention is the key to growth. That is the challenge – and opportunity. […] Read more

The Deloitte M&A Index – 2016: Opportunities Amidst Divergence

M&A Index – 2016: Opportunities Amidst Divergence

by Deloitte
We are expecting 2015 to end with over $4 trillion worth of deals making it the highest for deal values since 2007. However, on a last-twelve-months (LTM) basis, there was a slowdown in the volume of transactions in the second half of 2015. Cross-border deals are a major feature of this M&A wave. More than $1 trillion worth of cross-border deals have been announced so far this year, of which a third were in the vibrant deal corridor between North America and Europe. […] Read more

When Do Acquirers Invest In The R&D Assets Of Acquired Science-Based Firms In Cross-Border Acquisitions?

Table 1 Sample firm characteristics

by Elsevier Ltd.
Drawing on a multiple case study of acquisitions of UK biopharmaceutical firms, we develop an analytical framework that elucidates how key determinants of the knowledge base of science-based firms and their combinations through M&As interact and affect post-acquisition investment in the target’s R&D projects. […] Read more

Cross-Border Deal Making In The High-Tech Industry: Lessons Learned From An M&A Transaction

Cross-Border Deal Making In The High-Tech Industry

by Willis Towers Watson
With merger and acquisition (M&A) activity heating up worldwide, two Towers Watson M&A experts met with Karen Gaydon, a successful U.S.-based deal maker whose team at Synaptics recently closed the acquisition of a joint venture in Japan. This article, which summarizes their discussion, includes insights from all three on M&A trends in the high-tech industry, as well as valuable information about M&A success factors. […] Read more

Are you sure you
want to log out?

Request a Brochure

Request a Brochure

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!

Book a Demo

Book a Demo

Contact us to discuss your goals and needs!

Contact us to discuss your goals and needs!